anfepramona
anfepramona Brand names, anfepramona Analogs
- Adiposon
- Amfepramon
- Amfepramone
- Amfepramone HCL
- Amfepramone Hydrochloride
- Amfepramonum [INN-Latin]
- Amphepramon
- Amphepramone
- Amphepramonum hydrochloride
- Anfamon
- Anfepramona [INN-Spanish]
- Anorex
- Cegramine
- DEA No. 1610
- Danylen
- Derfon
- Diethylpropion HCL
- Diethylpropion Hydrochloride
- Diethylpropione
- Diethylpropione hydrochloride
- Dobesin
- Frekentine
- Keramik
- Keramin
- Magrene
- Moderatan
- Modulor
- Neobes
- Nopropiophenone
- Obesitex
- Parabolin
- Prefamone
- Regenon
- Regenon hydrochloride
- Reginon
- Silutin
- Tenuate
- Tenuate Dospan
- Tenuate hydrochloride
- Tepanil
- Tepanil Ten-tab
- Tylinal
- alpha-Benzoyltriethylamine
- alpha-Diethylaminopropiophenone
anfepramona Brand Names Mixture
- No information avaliable
anfepramona Chemical_Formula
C13H19NO
anfepramona RX_link
http://www.rxlist.com/cgi/generic3/diethprop.htm
anfepramona fda sheet
anfepramona msds (material safety sheet)
anfepramona Synthesis Reference
No information avaliable
anfepramona Molecular Weight
205.296 g/mol
anfepramona Melting Point
No information avaliable
anfepramona H2O Solubility
No information avaliable
anfepramona State
No information avaliable
anfepramona LogP
2.951
anfepramona Dosage Forms
25 mg tablets and 75 mg controlled-release tablets.
anfepramona Indication
Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.
anfepramona Pharmacology
Diethylpropion is a sympathomimetic stimulant drug marketed as an appetite suppressant. Chemically, it is the N,N-diethyl analog of cathinone. Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dextroamphetamine.
anfepramona Absorption
Diethylpropion is rapidly absorbed from the GI tract after oral administration.
anfepramona side effects and Toxicity
The reported oral LD50 for mice is 600 mg/kg, for rats is 250 mg/kg and for dogs is 225 mg/kg. Manifestation of acute overdosage include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, and panic states.
anfepramona Patient Information
No information avaliable
anfepramona Organisms Affected
Humans and other mammals
